http://rdf.ncbi.nlm.nih.gov/pubchem/patent/TW-I226886-B
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7f6e33603375c486b0ab3505830af9e8 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D211-46 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-46 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4465 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D207-12 |
filingDate | 2000-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2005-01-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9860e4e1db402ae306b8d8c0128a92c9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4d507394b711c3309437cc8b180dcb2b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ca7472a977909941d1ec76be45bc5768 |
publicationDate | 2005-01-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | TW-I226886-B |
titleOfInvention | Benzamidine derivatives and the pharmacologically acceptable salts thereof, and the pharmaceutical composition thereof for treating or preventing blood coagulation diseases |
abstract | Benzamidine derivatives of the formula (I), [wherein, R1 is H, a halogen atom, an alkyl group or hydroxyl group; R2 is H, a halogen atom or an alkyl group, R3 is H, an optionally substituted alkyl group, an aralkyl group, an optionally substituted alkanoyl group or an optionally substituted alkylsulfonyl group, R4 and R 5 are the same or different, each represents H, halogen, an optionally substituted alkyl group, an alkoxy group, carboxyl group, an alkoxycarbonyl group or an optionally substituted carbamoyl group, R6 is a substituted pyrrolidinyl group or substituted piperidinyl group] or the pharmaceutically acceptable salts thereof, which have an excellent activated blood coagulation factor X inhibiting effect and useful for treating preventing blood coagulation diseases. |
priorityDate | 1999-10-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 790.